Regulatory & Legal

A South Florida group is skipping the fancy awards dinner to honor women leaders in their own workplaces, proving that the most meaningful praise is personal.

A unique $4M award program aims to solve a critical funding gap, accelerating high-risk, high-reward cancer therapies from academic labs to patients.

A new MMA league is letting fans and fighters buy in. With veteran leaders and a $5M equity raise, can the Global Fight League disrupt the octagon?

A new partnership embeds real-time tax determination into spend management, aiming to eliminate compliance risks and streamline financial workflows.

SEAM, Inc. appoints a new COO and CMO, signaling a strategic move to scale its social equity certification and meet the growing demand for people-first real estate.

Cherry Hill facility's Joint Commission accreditation signals a new benchmark for quality and safety in addiction recovery for New Jersey families.

Securus Monitoring touts high-tech supervision tools for modern reentry, but its parent company's controversial history casts a long shadow over its promises.

A new partnership in Brazil will use light-powered tech to turn agricultural waste into SAF, part of a plan to build a 1M ton global supply chain.

The organic food pioneer gets 37 products certified under a new standard, signaling a major shift toward transparency in the fight against ultra-processed food.

With $65M in new funding and a new CEO, Duos is betting big on a $200M NVIDIA GPU deal to become a key player in the booming Edge AI infrastructure market.

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

Daxor reports a transformative year with 45% revenue growth, a new FDA-cleared portable analyzer, and a full pivot to a high-growth medtech company.

With a 10-K filed and new acquisitions, THC Therapeutics is fighting to shed its obscure market status and build a vertically integrated cannabis powerhouse.

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

The aerial firefighting giant lands a major DOI contract for Alaskan transport, signaling a strategic shift into year-round government logistics.

The neurohealth firm surpassed revenue estimates and hit positive cash flow, but a dynamic competitive landscape and CEO transition loom ahead of its earnings call.

A new deal brings Nanox's low-radiation, cost-effective Nanox.ARC to orthopedic clinics, aiming to reshape point-of-care diagnostics in the region.

A new partnership between Dstillery, Keynes, and The Trade Desk cuts a 48-hour workflow to 5 minutes, heralding a new era of autonomous AI in advertising.

As Akebia heads to a major conference, investors watch its Vafseo launch, new rare disease pipeline, and path to profitability. Here's what's at stake.

As shadow AI and autonomous agents create huge risks, Teramind's new platform offers total visibility to help firms innovate without sacrificing security.